United States AI in Drug Discovery Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

1.  Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.  Executive Summary

3.  Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.4.  Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for the United States AI in Drug Discovery Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Value Chain Analysis of the United States AI in Drug Discovery Market

3.7.  Competitive Landscape in the United States AI in Drug Discovery Market

4.  The United States AI in Drug Discovery Market by Offering

4.1.  Software

4.2.  Services

5.  The United States AI in Drug Discovery Market by Technology

5.1.  Machine Learning

5.2.  Natural Language Processing (NLP)

5.3.  Computer Vision

5.4.  Others

6.  The United States AI in Drug Discovery Market by Application

6.1.  Target Identification

6.2.  Molecule Screening

6.3.  Drug Design and Drug Optimization

6.4.  Preclinical and Clinical Testing

6.5.  Others

7.  The United States AI in Drug Discovery Market by Therapeutic Area

7.1.  Oncology

7.2.  Neurodegenerative Diseases

7.3.  Infectious Disease

7.4.  Others

8.  The United States AI in Drug Discovery Market by End User

8.1.  Pharmaceutical & Biotechnology Companies

8.2.  Contract Research Organizations

8.3.  Academic & Government Research Institutes

9.  Company Profiles

9.1.  Company 1

9.2.  Company 2

9.3.  Company 3

9.4.  Company 4

9.5.  Company 5